Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v6-FR
Language French French
Date Updated 2020-12-01 2020-11-20
Drug Identification Number 02243562 02243562
Brand name HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG
Common or Proper name NHYDROMORPH CONTIN NHYDROMORPH CONTIN
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 18MG 18MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-11-06 2020-11-06
Actual start date 2020-11-16 2020-11-16
Estimated end date 2020-11-30 2020-11-30
Actual end date 2020-11-26
Shortage status Resolved Actual shortage
Company comments
Health Canada comments